Published in Hippokratia on January 01, 2011
Development and Validation of a Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient Settings. PLoS One (2017) 1.39
The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol Rev (2015) 0.99
Sphingobacterium spiritivorum infection in a patient with end stage renal disease on haemodialysis. Ann Clin Microbiol Antimicrob (2016) 0.86
Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World J Gastroenterol (2014) 0.82
Temporal trends and factors associated with pediatric hospitalizations with respiratory infection. J Asthma (2015) 0.75
Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options. Biomed Res Int (2017) 0.75
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA (1994) 14.96
Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet (2006) 7.82
Staphylococcus aureus resistant to vancomycin--United States, 2002. MMWR Morb Mortal Wkly Rep (2002) 7.34
Clinical practice guidelines for vascular access. Am J Kidney Dis (2006) 6.71
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med (2009) 5.73
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet (2005) 5.70
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet (2009) 3.98
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis (2006) 3.70
Clinical practice guidelines for vascular access. Am J Kidney Dis (2006) 3.19
The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. Am J Epidemiol (1975) 2.81
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int (2000) 2.80
Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients. Am J Kidney Dis (2007) 2.39
A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis (2008) 2.38
Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis (2004) 2.28
Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med (2009) 2.24
Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med (2005) 2.18
Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med (1997) 2.10
Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA (1991) 2.07
Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med (2008) 2.06
Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. J Am Soc Nephrol (2003) 1.88
Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis (2007) 1.81
Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am J Kidney Dis (2009) 1.79
Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 1.78
"Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events. J Infect Dis (2009) 1.77
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. Antimicrob Agents Chemother (2007) 1.72
Tuberculin and anergy skin testing of patients receiving long-term hemodialysis. Chest (1998) 1.70
Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol (2004) 1.70
Performance of rapid influenza diagnostic tests during two school outbreaks of 2009 pandemic influenza A (H1N1) virus infection - Connecticut, 2009. MMWR Morb Mortal Wkly Rep (2009) 1.66
Effectiveness and safety of dialysis vascular access procedures performed by interventional nephrologists. Kidney Int (2004) 1.65
The value of vaccination in chronic kidney disease. Semin Dial (2004) 1.65
Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep (1995) 1.64
Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant (2009) 1.63
Ruling out novel H1N1 influenza virus infection with direct fluorescent antigen testing. Clin Infect Dis (2009) 1.62
Disturbances of acquired immunity in hemodialysis patients. Semin Dial (2007) 1.57
Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev (2001) 1.50
Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant (2004) 1.50
Update on influenza A (H1N1) 2009 monovalent vaccines. MMWR Morb Mortal Wkly Rep (2009) 1.45
Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients. Blood Purif (2008) 1.43
Tuberculosis and chronic renal disease. Semin Dial (2003) 1.41
Pulmonary infectious mortality among patients with end-stage renal disease. Chest (2001) 1.40
Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int (2003) 1.36
The use of vaccines in adult patients with renal disease. Am J Kidney Dis (2005) 1.33
Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis (1999) 1.32
Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int (2002) 1.31
Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States, 2005. MMWR Morb Mortal Wkly Rep (2007) 1.31
The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (2006) 1.30
Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol (1999) 1.29
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine (2009) 1.27
Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol (2003) 1.25
Change in vascular access and mortality in maintenance hemodialysis patients. Am J Kidney Dis (2009) 1.25
Hepatitis C virus infection and the dialysis patient. Semin Dial (2007) 1.24
The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis (2007) 1.22
Multidrug-resistant tuberculosis outbreak on an HIV ward--Madrid, Spain, 1991-1995. MMWR Morb Mortal Wkly Rep (1996) 1.20
Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control (2004) 1.19
Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis (2009) 1.18
Induction of lupus autoantibodies by adjuvants. J Autoimmun (2003) 1.18
Tuberculosis infection and anergy in hemodialysis patients. Am J Kidney Dis (1998) 1.16
A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant (2002) 1.12
Increased incidence of tuberculosis in patients undergoing hemodialysis. Nephron (1996) 1.10
Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol (2008) 1.10
MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. Vaccine (2009) 1.08
Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis (1992) 1.07
Tuberculosis in maintenance dialysis patients. Nephron (2001) 1.05
Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis (2002) 1.05
Risk of tuberculosis in dialysis patients: a population-based study. Int J Tuberc Lung Dis (1998) 1.03
Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int (1998) 1.03
Cefazolin as empiric therapy in hemodialysis-related infections: efficacy and blood concentrations. Am J Kidney Dis (1998) 1.02
Tuberculosis in patients with end-stage renal disease. Int J Tuberc Lung Dis (2004) 0.99
Human immunodeficiency virus infection in end-stage renal disease patients. Semin Dial (2003) 0.98
Hepatitis B virus infection and the dialysis patient. Semin Dial (2008) 0.97
Successful use of cuffed central venous hemodialysis catheters inserted percutaneously. J Am Soc Nephrol (1994) 0.96
Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: management by guidewire exchange. Am J Kidney Dis (1995) 0.94
Distinctive patterns of autoimmune response induced by different types of mineral oil. Toxicol Sci (2004) 0.94
Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination. Am J Nephrol (2006) 0.93
Infection associated with tunneled hemodialysis catheters. Semin Dial (2008) 0.92
Risks related to catheter locking solutions containing concentrated citrate. Nephrol Dial Transplant (2003) 0.92
Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis (2008) 0.91
Cannulation of subclavian vein for hemodialysis using Seldinger's technique. Trans Am Soc Artif Intern Organs (1978) 0.90
Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis. Clin Exp Immunol (2007) 0.90
Electronic reporting of infections associated with hemodialysis. Nephrol News Issues (2005) 0.90
Eleven years of experience with dialysis associated tuberculosis. Clin Nephrol (2002) 0.90
Changing subclavian haemodialysis cannulas to reduce infection. Lancet (1981) 0.89
Clonal relatedness of methicillin-resistant coagulase-negative staphylococci in the haemodialysis unit of a single university centre in Greece. Nephrol Dial Transplant (2008) 0.88
Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. J Med Virol (2007) 0.87
Extrapulmonary tuberculosis in chronic hemodialysis patients. Ren Fail (2003) 0.84
Induction of lupus-related specific autoantibodies by non-specific inflammation caused by an intraperitoneal injection of n-hexadecane in BALB/c mice. Toxicology (2005) 0.83
Tuberculosis screening in dialysis patients--is the tuberculin test effective? Clin Nephrol (2003) 0.83
Tuberculosis in hemodialysis patients in New Jersey: a statewide study. Infect Control Hosp Epidemiol (1999) 0.82
The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes. Clin Exp Immunol (2002) 0.82
Chronic inflammation and T cell zeta-chain downregulation in hemodialysis patients. Am J Nephrol (2007) 0.81
Incidence of subclavian dialysis catheter-related infections. Arch Intern Med (1984) 0.81
The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients. Am J Kidney Dis (2005) 0.81
Efficacy of pneumococcal immunization in patients with renal disease--what is the data? Am J Nephrol (2004) 0.81
Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis (1990) 0.81
Does tuberculosis after kidney transplantation follow the trend of tuberculosis in general population? Ren Fail (2001) 0.80
Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidone-iodine. Postgrad Med J (1993) 0.80
Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect Control Hosp Epidemiol (1995) 0.80
Influence of hemodialysis on the mean blood flow velocity in the middle cerebral artery. Clin Nephrol (2005) 1.09
Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity. J Gastroenterol (2011) 1.06
Acute renal failure after antibiotic-impregnated bone cement treatment of an infected total knee arthroplasty. Clin Nephrol (2008) 0.98
A case of membranous nephropathy associated with Sjögren syndrome, polymyositis and autoimmune hepatitis. Clin Nephrol (2008) 0.96
Hepatitis E virus antibodies in hemodialysis patients: an epidemiological survey in central Greece. Int J Artif Organs (2004) 0.96
Estradiol and leptin as conditional prognostic IVF markers. Reproduction (2005) 0.93
Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections. Hippokratia (2011) 0.90
Fibrates: therapeutic potential for diabetic nephropathy? Eur J Intern Med (2012) 0.88
Renal cell carcinoma in peritoneal dialysis patients. Int Urol Nephrol (2003) 0.87
Low RLS prevalence and awareness in central Greece: an epidemiological survey. Eur J Neurol (2007) 0.87
Selenium deficiency and thyroid function in acute renal failure. Ren Fail (1997) 0.86
The diabetic foot in end stage renal disease. Ren Fail (2007) 0.86
Group B Streptococcus (Streptococcus agalactiae) peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol (2004) 0.81
Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece. Sleep Med (2013) 0.80
A bioequivalence study of levothyroxine tablets versus an oral levothyroxine solution in healthy volunteers. Eur J Drug Metab Pharmacokinet (2006) 0.79
Effect of adrenaline on transmesothelial resistance of isolated sheep pleura. Respir Physiol Neurobiol (2006) 0.78
Hirudin elimination by hemofiltration: a comparative in vitro study of different membranes. Kidney Int Suppl (1999) 0.78
Suppression of humoral immune response to hepatitis B surface antigen vaccine in BALB/c mice by 1-methyl-tryptophan co-administration. Daru (2011) 0.78
Urinary thymidine glycol as a biomarker for oxidative stress after kidney transplantation. Ren Fail (2000) 0.78
Mitochondrial changes in muscle phosphoglycerate kinase deficiency. Clin Neuropathol (1997) 0.77
L-arginine supplementation does not affect chemically induced carcinogenesis and tumor growth in BALB-c mice. Hippokratia (2007) 0.77
Is there a link between inflammation, plasma resistin levels, and protein malnutrition in hemodialysis patients? Kidney Int (2006) 0.77
Intermittent intraperitoneal dose of teicoplanin in peritoneal dialysis-related peritonitis. Perit Dial Int (2012) 0.76
Aeromonas hydrophila as a causative organism in peritoneal dialysis-related peritonitis: case report and review of the literature. Clin Nephrol (2011) 0.76
Differential diagnosis of hyperkalemia: an update to a complex problem. Hippokratia (2012) 0.75
Pulmonary renal syndrome in an adult patient with Henoch-Shönlein purpura. Hippokratia (2006) 0.75
Lipopolysaccharide and hypoxia significantly alters interleukin-8 and macrophage chemoattractant protein-1 production by human fibroblasts but not fibrosis related factors. Hippokratia (2011) 0.75
Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients. Perit Dial Int (2006) 0.75
Aquaporin-1 and sodium transport in the peritoneal membrane--need for more research? Kidney Int (2006) 0.75
The peritoneal equilibration test should be included in routine monitoring of peritoneal dialysis patients. Perit Dial Int (2012) 0.75
Prevention of haemodynamic risks by continuous blood volume measurement and control. Nephrol Dial Transplant (1996) 0.75
Expression of transforming growth factor-beta receptor II mRNA in cyclosporine-induced gingival overgrowth. Transplant Proc (2006) 0.75
Accidental acute metabolic acidosis due to inappropriate selection of bicarbonate concentrate. EDTNA ERCA J (2005) 0.75
[Persistent thrombophilia in a 35-year-old patient with Budd-Chiari syndrome]. Internist (Berl) (1994) 0.75
The heterogeneous and delayed course of blood pressure normalization in hypertensive patients after bilateral nephrectomy with and without subsequent renal transplantation. Ren Fail (2000) 0.75
Filtration fluid for hemodialysis treatment. Int J Artif Organs (2002) 0.75
Plasma vascular endothelial growth factor and angiogenin are positively related to erythropoietin dose in hemodialysis patients. Adv Med Sci (2013) 0.75
Influence of recombinant human erythropoietin on hematological and hemostatic parameters with special reference to microhemolysis. Clin Nephrol (1995) 0.75